Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
3.650
-0.090 (-2.41%)
At close: Jun 27, 2025, 4:00 PM
3.700
+0.050 (1.37%)
After-hours: Jun 27, 2025, 7:48 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Therapeutics
194.62M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-33.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
194.62M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.46%
Log In
Log In
Log In
Log In
Upgrade